Patents Assigned to Progastrine et Cancers S.À R.L.
  • COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER
    Publication number: 20240085423
    Abstract: The present invention relates to methods for the in vitro diagnosis of esophageal cancer, and to compositions and methods for the prevention or the treatment of esophageal cancer. Disclosed are compositions that include an antibody binding to progastrin and disclosed are methods that include the use of an antibody binding to progastrin.
    Type: Application
    Filed: September 15, 2023
    Publication date: March 14, 2024
    Applicant: Progastrine et Cancers S.à r.l.
    Inventor: Alexandre PRIEUR
  • COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER
    Publication number: 20240018264
    Abstract: The present invention relates to methods for the in vitro diagnosis of ovarian cancer, and to compositions and methods for the prevention or the treatment of ovarian cancer. Disclosed are compositions that include an antibody binding to progastrin and disclosed are methods that include the use of an antibody binding to progastrin.
    Type: Application
    Filed: July 26, 2023
    Publication date: January 18, 2024
    Applicant: Progastrine et Cancers S.à r.l.
    Inventor: Alexandre PRIEUR
  • Compositions and methods for detecting and treating esophageal cancer
    Patent number: 11789021
    Abstract: The present invention relates to methods for the in vitro diagnosis of esophageal cancer, and to compositions and methods for the prevention or the treatment of esophageal cancer. Disclosed are said compositions that include an antibody binding to progastrin and disclosed are methods that include the use of an antibody binding to progastrin.
    Type: Grant
    Filed: January 2, 2017
    Date of Patent: October 17, 2023
    Assignee: PROGASTRINE ET CANCERS S.À R.L.
    Inventor: Alexandre Prieur
  • Compositions and methods for detecting and treating ovarian cancer
    Patent number: 11760808
    Abstract: The present invention relates to methods for the in vitro diagnosis of ovarian cancer, and to compositions and methods for the prevention or the treatment of ovarian cancer. Disclosed are compositions that include an antibody binding to progastrin and disclosed are methods that include the use of an antibody binding to progastrin.
    Type: Grant
    Filed: January 2, 2017
    Date of Patent: September 19, 2023
    Assignee: Progastrine et Cancers S.À R.L.
    Inventor: Alexandre Prieur
  • Compositions and methods for detecting and treating prostate cancer using progastrin binding molecule
    Patent number: 11644468
    Abstract: The present invention relates to compositions and methods for the prevention or the treatment of prostate cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: May 9, 2023
    Assignee: Progastrine et Cancers S.à r.L
    Inventor: Alexandre Prieur
  • Compositions and methods for treating lung cancer
    Patent number: 11561225
    Abstract: The present invention relates to compositions and methods for the prevention or the treatment of lung cancer, wherein the compositions comprise an antibody binding to progastrin and the methods comprise the use of an antibody binding to progastrin.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: January 24, 2023
    Assignee: Progastrine et Cancers S.à r.l.
    Inventor: Alexandre Prieur
  • COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER
    Publication number: 20210324069
    Abstract: The present invention relates to combinations comprising anti-progastrin (anti-hPG) monoclonal antibodies and immune checkpoint inhibitors, as well as pharmaceutical compositions comprising said combinations. Methods of treatment of cancer using said combinations are also provided.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Applicant: Progastrine et Cancers S.À R.L.
    Inventor: Alexandre Prieur
  • Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
    Patent number: 11046758
    Abstract: The present invention relates to combinations comprising anti-progastrin (anti-hPG) monoclonal antibodies and immune checkpoint inhibitors, as well as pharmaceutical compositions comprising said combinations. Methods of treatment of cancer using said combinations are also provided.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: June 29, 2021
    Assignee: PROGASTRINE ET CANCERS S.À R.L.
    Inventor: Alexandre Prieur
  • COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER
    Publication number: 20210085784
    Abstract: The present invention relates to compositions and methods for the prevention or the treatment of lung cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.
    Type: Application
    Filed: March 30, 2018
    Publication date: March 25, 2021
    Applicant: Progastrine et Cancers S.à r.l.
    Inventor: Alexandre Prieur
  • COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CANCER USING PROGASTRIN BINDING MOLECULE
    Publication number: 20210087265
    Abstract: The present invention relates to compositions and methods for the prevention or the treatment of prostate cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.
    Type: Application
    Filed: March 30, 2018
    Publication date: March 25, 2021
    Applicant: Progastrine et Cancers S.à r.l.
    Inventor: Alexandre Prieur
  • COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER
    Publication number: 20210009680
    Abstract: The present invention relates to combinations comprising anti-progastrin (anti-hPG) monoclonal antibodies and immune checkpoint inhibitors, as well as pharmaceutical compositions comprising said combinations. Methods of treatment of cancer using said combinations are also provided.
    Type: Application
    Filed: December 5, 2018
    Publication date: January 14, 2021
    Applicant: Progastrine et Cancers S.À R.L.
    Inventor: Alexandre Prieur
  • COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER
    Publication number: 20190011447
    Abstract: The present invention relates to methods for the in vitro diagnosis of esophageal cancer, and to compositions and methods for the prevention or the treatment of esophageal cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.
    Type: Application
    Filed: January 2, 2017
    Publication date: January 10, 2019
    Applicant: Progastrine et Cancers S.À R.L.
    Inventor: Alexandre Prieur
  • COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER
    Publication number: 20190011449
    Abstract: The present invention relates to methods for the in vitro diagnosis of gastric cancer, and to compositions and methods for the prevention or the treatment of gastric cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.
    Type: Application
    Filed: January 2, 2017
    Publication date: January 10, 2019
    Applicant: Progastrine et Cancers S.À R.L.
    Inventor: Alexandre Prieur
  • COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER
    Publication number: 20190002582
    Abstract: The present invention relates to methods for the in vitro diagnosis of ovarian cancer, and to compositions and methods for the prevention or the treatment of ovarian cancer, wherein said compositions comprise an antibody binding to progastrin and said methods comprise the use of an antibody binding to progastrin.
    Type: Application
    Filed: January 2, 2017
    Publication date: January 3, 2019
    Applicant: Progastrine et Cancers S.À R.L.
    Inventor: Alexandre Prieur